Skip to main content

Table 4 Novel mortality prediction models for ALF-patients receiving ECMO support

From: Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study

  Coefficient OR 95% CI
Model 1 (pre-ECMO)    
Age (per five years) 0.176 1.193 (1.148 to 1.239)
Immunocompromised state 0.958 2.605 (1.316 to 5.158)
Minute ventilation (L/minute) 0.098 1.103 (1.014 to 1.199)
Pre-ECMO hemoglobin (g/dL) -0.182 0.834 (0.728 to 0.954)
Pre-ECMO lactate (mmol/L) 0.013 1.013 (1.004 to 1.023)
Intercept -2.083   
Model 2 (Day 1)    
Age (per five years) 0.184 1.202 (1.148 to 1.258)
Immunocompromised state 1.093 2.984 (1.394 to 6.391)
Minute ventilation (L/minute) 0.137 1.147 (1.030 to 1.276)
Pre-ECMO hemoglobin (g/dL) -0.208 0.812 (0.696 to 0.947)
Day 1 FiO2 (per 10%) 0.264 1.302 (1.232 to 1.376)
Day 1 fibrinogen (mg/dL) -0.002 0.998 (0.996 to 0.999)
Day 1 norepinephrine (μg/minute/10 kg) 0.159 1.172 (0.980 to 1.401)
Day 1 C-reactive protein (mg/L) -0.004 0.996 (0.992 to 0.999)
Intercept -1.893   
  1. ALF, acute lung failure; CI, confidence interval; ECMO, extracorporeal membrane oxygenation; FiO2, fraction of inspired oxygen; OR, odds ratio.